CircHIPK3 promotes neuroinflammation through regulation of the miR-124-3p/STAT3/NLRP3 signaling pathway in Parkinson’s disease
Advances in Clinical and Experimental Medicine · 28.10.2022 · 32 (3) · 315-329
DOI: 10.17219/acem/154658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, online erschienen am 28.10.2022. Verfasst von Yu-Juan Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine College, Guangzhou University of Chinese Medicine, China. Hauptthemen laut MEDLINE: Parkinson Disease, Neurodegenerative Diseases, Neuroblastoma, MicroRNAs. Die Arbeit wurde bisher 45-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medicine College, Guangzhou University of Chinese Medicine, China.
- Department of Acupuncture, Linyi People's Hospital, China.
- Department of Neurology, Linyi People's Hospital, China.
Zitieren
APA
Zhang, Y. J., Zhu, W. K., Qi, F. Y., & Che, F. Y. (2022). CircHIPK3 promotes neuroinflammation through regulation of the miR-124-3p/STAT3/NLRP3 signaling pathway in Parkinson’s disease. Advances in Clinical and Experimental Medicine, 32(3), 315-329. https://doi.org/10.17219/acem/154658
Vancouver
Zhang YJ, Zhu WK, Qi FY, Che FY. CircHIPK3 promotes neuroinflammation through regulation of the miR-124-3p/STAT3/NLRP3 signaling pathway in Parkinson’s disease. Advances in Clinical and Experimental Medicine. 2022;32(3):315-329. doi:10.17219/acem/154658
BibTeX
@article{Zhang2022,
author = {Zhang, Yu-Juan and Zhu, Wen-Kai and Qi, Fa-Ying and Che, Feng-Yuan},
title = {CircHIPK3 promotes neuroinflammation through regulation of the miR-124-3p/STAT3/NLRP3 signaling pathway in Parkinson’s disease},
journal = {Advances in Clinical and Experimental Medicine},
year = {2022},
volume = {32},
number = {3},
pages = {315--329},
doi = {10.17219/acem/154658}
}
EUVIMED